Newborn screening for congenital hypothyroidism, Victoria, Australia, 1977-1997. Part 1: The screening programme,

J F Connelly1, J C Coakley, H Gold

  • 1Department of Clinical Biochemistry, Royal Children's Hospital, Parkville, Victoria, Australia. connelly@labyrinth.net.au

Insights

Congenital hypothyroidism (CH) affects 1 in 3,541 infants in Victoria, Australia. Thyroid ectopia, aplasia, and dyshormonogenesis are the primary causes, with specific risk factors identified for each.

Area of Science:

  • Endocrinology
  • Pediatrics
  • Genetics

Background:

  • Congenital hypothyroidism (CH) is a common endocrine disorder in newborns.
  • Early detection and treatment are crucial for neurodevelopmental outcomes.
  • Understanding the aetiologies and demographics of CH is essential for public health initiatives.

Purpose of the Study:

  • To report clinical, demographic, and laboratory data of infants with CH in Victoria, Australia.
  • To establish a baseline for a long-term prospective study on CH outcomes.
  • To identify the prevalence and common aetiologies of CH in the screened population.

Main Methods:

  • Neonatal screening using a primary TT4 test.
  • Prospective data collection via a clinical assessment protocol.
  • 99mTc pertechnetate scanning for aetiological determination.

Main Results:

  • 199 cases of permanent primary CH identified in 704,723 screened infants (1:3,541 prevalence).
  • Most common aetiologies: thyroid ectopia (46%), aplasia (33%), and dyshormonogenesis (11%).
  • Clinical features varied by aetiology; female preponderance noted in thyroid dysplasia; increased dyshormonogenesis in infants of Middle-Eastern origin.

Conclusions:

  • The study provides a comprehensive dataset on CH in Victoria, Australia.
  • Identified prevalence and aetiologies align with global trends but highlight specific demographic associations.
  • This data serves as a critical baseline for future research on long-term CH outcomes.

Related Concept Videos